{"id":6,"date":"2024-11-14T15:57:25","date_gmt":"2024-11-14T15:57:25","guid":{"rendered":"https:\/\/www.brineura.com\/en-us\/?page_id=6"},"modified":"2026-03-12T13:44:13","modified_gmt":"2026-03-12T13:44:13","slug":"home","status":"publish","type":"page","link":"https:\/\/www.brineura.com\/en-us\/","title":{"rendered":"Home"},"content":{"rendered":"
\n
<\/div>\n\t
<\/div>\n \t
<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t \t\t\t\t\t\t\t\t\t\t\t\t

Take the first step with Brineura® (cerliponase alfa)\n<\/h1>\n\t\t\t\t\t\t\t\t\t\t\t\t

Helping make more steps possible by slowing loss of walking ability<\/strong><\/p>\n

BRINEURA®<\/sup> (cerliponase alfa) is a prescription medication used to slow loss of ability to walk or crawl (ambulation) in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency.<\/p>\n

Connect with BioMarin to learn more about Brineura<\/strong><\/p>\n\t\t\t\t\t\t\t\t\n

\n \t\t\t\t Register Now<\/a>\t\t\t\t <\/p>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n

\n\t
\n\t\t
\n\t\t
\n \n \n \n \n
\n
\n \"\"\/ <\/div>\n <\/figure>\n <\/div>\n \n
\n

Learn how Brineura may help your child<\/h4>\n

About Brineura<\/a><\/p>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>\n\n

\n\t
\n\t\t
\n\t\t
\n \n \n \n \n
\n
\n \"\"\/ <\/div>\n <\/figure>\n <\/div>\n \n
\n

Brineura helped maintain children’s ability to walk, with or without assistance, over years of treatment<\/h4>\n

Brineura Study Results<\/a><\/p>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>\n\n

\n\t
\n\t\t
\n\t\t
\n \n \n \n \n
\n
\n \"\"\/ <\/div>\n <\/figure>\n <\/div>\n \n
\n

Discover the path toward treatment with Brineura<\/h4>\n

Every child’s journey with Brineura will be different.<\/p>\n

Getting Started With Brineura<\/a><\/p>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>\n\n

\n\t
\n\t\t
\n\t\t
\n \n \n \n \n
\n
\n \"\"\/ <\/div>\n <\/figure>\n <\/div>\n \n
\n

We’re here for you and your family with resources<\/h4>\n

Brineura Family Resources<\/a><\/p>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-6","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nHome - BioMarin Brineura Patient EN-US<\/title>\n<meta name=\"description\" content=\"BRINEURA\u00ae (cerliponase alfa) is a prescription medication used to slow loss of ability to walk or crawl (ambulation) in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.brineura.com\/en-us\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Home\" \/>\n<meta property=\"og:description\" content=\"BRINEURA\u00ae (cerliponase alfa) is a prescription medication used to slow loss of ability to walk or crawl (ambulation) in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.brineura.com\/en-us\/\" \/>\n<meta property=\"og:site_name\" content=\"BioMarin Brineura Patient EN-US\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-12T13:44:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.brineura.com\/en-us\/\",\"url\":\"https:\/\/www.brineura.com\/en-us\/\",\"name\":\"Home - BioMarin Brineura Patient EN-US\",\"isPartOf\":{\"@id\":\"https:\/\/www.brineura.com\/en-us\/#website\"},\"datePublished\":\"2024-11-14T15:57:25+00:00\",\"dateModified\":\"2026-03-12T13:44:13+00:00\",\"description\":\"BRINEURA\u00ae (cerliponase alfa) is a prescription medication used to slow loss of ability to walk or crawl (ambulation) in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.brineura.com\/en-us\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.brineura.com\/en-us\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.brineura.com\/en-us\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.brineura.com\/en-us\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.brineura.com\/en-us\/#website\",\"url\":\"https:\/\/www.brineura.com\/en-us\/\",\"name\":\"BioMarin Brineura Patient EN-US\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.brineura.com\/en-us\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Home - BioMarin Brineura Patient EN-US","description":"BRINEURA\u00ae (cerliponase alfa) is a prescription medication used to slow loss of ability to walk or crawl (ambulation) in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.brineura.com\/en-us\/","og_locale":"en_US","og_type":"article","og_title":"Home","og_description":"BRINEURA\u00ae (cerliponase alfa) is a prescription medication used to slow loss of ability to walk or crawl (ambulation) in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency.","og_url":"https:\/\/www.brineura.com\/en-us\/","og_site_name":"BioMarin Brineura Patient EN-US","article_modified_time":"2026-03-12T13:44:13+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.brineura.com\/en-us\/","url":"https:\/\/www.brineura.com\/en-us\/","name":"Home - BioMarin Brineura Patient EN-US","isPartOf":{"@id":"https:\/\/www.brineura.com\/en-us\/#website"},"datePublished":"2024-11-14T15:57:25+00:00","dateModified":"2026-03-12T13:44:13+00:00","description":"BRINEURA\u00ae (cerliponase alfa) is a prescription medication used to slow loss of ability to walk or crawl (ambulation) in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2 disease), also known as tripeptidyl peptidase 1 (TPP1) deficiency.","breadcrumb":{"@id":"https:\/\/www.brineura.com\/en-us\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.brineura.com\/en-us\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.brineura.com\/en-us\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.brineura.com\/en-us\/"},{"@type":"ListItem","position":2,"name":"Home"}]},{"@type":"WebSite","@id":"https:\/\/www.brineura.com\/en-us\/#website","url":"https:\/\/www.brineura.com\/en-us\/","name":"BioMarin Brineura Patient EN-US","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.brineura.com\/en-us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.brineura.com\/en-us\/wp-json\/wp\/v2\/pages\/6","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.brineura.com\/en-us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.brineura.com\/en-us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.brineura.com\/en-us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.brineura.com\/en-us\/wp-json\/wp\/v2\/comments?post=6"}],"version-history":[{"count":56,"href":"https:\/\/www.brineura.com\/en-us\/wp-json\/wp\/v2\/pages\/6\/revisions"}],"predecessor-version":[{"id":692,"href":"https:\/\/www.brineura.com\/en-us\/wp-json\/wp\/v2\/pages\/6\/revisions\/692"}],"wp:attachment":[{"href":"https:\/\/www.brineura.com\/en-us\/wp-json\/wp\/v2\/media?parent=6"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}